340B In The News

The Hill: When drug prices threaten patient care

The debate over high drug prices has raged for decades, thanks to the inherent tension between delivering innovative and cost-effective patient care. But recently something has changed, and it’s one ...

Value Walk: How To Boost Drug Companies’ Profits Without Hurting Poor Americans

A Free Market Reform that Can Help Everybody Drug companies, like all for-profit companies, are all about profits. Their basic job is to take investors’ money and use it to ...

Modern Healthcare: Commentary: Guidance on 340B drug program delivers mismatch of policy, priorities from HHS

The Obama administration and HHS Secretary Sylvia Mathews Burwell have admirable goals for our nation’s healthcare system: greater provider collaboration; prevention and keeping people well after a hospital visit; payments ...

Drug Discount Monitor: Protect 340B, Cardiologist Asks Congress at Hearing on Drug Prices

The chief clinical officer of one of Indiana’s largest safety-net hospitals implored Congress to protect the 340B drug discount program in light of “hyperinflation in pharmaceutical pricing.” “I understand that ...

The Daily Caller: A Win For Drug Companies Leaves Taxpayers Holding The Bag

While drug company executives are enjoying rapidly escalating medicine prices, hardworking Americans are watching more and more of their paychecks disappear every month at the pharmacy. There’s a largely unknown ...

Want To Stay Up-To-Date On The Latest 340B News?

"*" indicates required fields